AGM 2018

Annual General Meeting 2018
Ascelia Pharma’s Annual General Meeting (Sw. årsstämma) was held at the premises of Setterwalls Advokatbyrå AB at Stortorget 23 in Malmö, Sweden on Friday 23 November 2018 at 11.00 a.m. Notice to the Annual General Meeting together with documents as per the agenda are found below.


Processing of personal data
The shares in Ascelia Pharma AB are registered at Euroclear Sweden AB (the Swedish Securities Register Center). For information on how your personal data is processed in Euroclear, see


Minutes AGM 23 November 2018 (ENG translation)


Documents for AGM 2018:

Notice to AGM 2018

Power of Attorney template AGM 2018

Proposal and reasoned statement from the Nomination Committee (SWE and ENG version included)

Instruction and charter for the Nomination Committee (SWE and ENG version included)

Report by the board on variable remuneration to senior executives (SWE and ENG version included)

Remuneration guidelines (SWE and ENG version included)

Proposal for authorization regarding authorization for new issues (SWE and ENG version included)

Proposal regarding resolution on cancellation of warrants (SWE and ENG version included)

Proposal for resolution regarding implementation of employee option program (SWE and ENG version included)

Annual Report 2017-2018 (English version)



About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)